Inspira Health and Cooper University Health Care recently announced a new partnership to build on the success of Cooper and Inspira Cardiac Care. This new venture, focused on neuroscience services, will allow patients to better access advanced care for conditions relating to the brain, spinal cord and central nervous system.
Cooper and Inspira Neuroscience will offer a full range of services across the care continuum, from prevention and diagnosis to treatment and rehabilitation, for both inpatients and outpatients.
Tudor G. Jovin, M.D., Chief of Neurology and Medical Director of the Neurological Institute at Cooper, will serve as the medical director of this program. Dr. Jovin has decades of experience with interventional and non-interventional treatments for the full spectrum of stroke and cerebrovascular disorders. He uses minimally invasive technologies applied from within the vessels to diagnose and treat spine and brain conditions such as acute stroke, carotid stenosis, intracranial aneurysm and arteriovenous malformations.
Conditions treated through this partnership will include stroke, brain tumors, peripheral cranial disorders, degenerative diseases, multiple sclerosis, spinal deformities and more. Treatment options will include both surgical and nonsurgical services such as medication management, rehabilitation therapy, deep brain stimulation, and endoscopic, robotic and minimally invasive surgeries.
“This partnership will provide patients with greater access to comprehensive care in the South Jersey region at both Cooper and Inspira,” said Matthew Brown, AVP of Cardiology and Neuroscience Service Lines at Inspira. “What’s more is that providers and their patients will benefit from improved evidence-based clinical protocols and standardized pathways, as well as an aligned research team.”
The teams involved in this partnership have a coordinated strategic plan to expand Cooper and Inspira Neuroscience services and subspecialties across the region. “We plan to build a more comprehensive program of services throughout both systems,” said Terri Veneziano, AVP of Clinical Neuroscience at Inspira. “Our goal is to expand access to services like thrombectomy, comprehensive spine treatment and functional and cognitive neurological care across our region, so patients can receive the comprehensive care they need in a setting close to home.”
The development of clinical pathways and integration of services through this partnership will result in seamless navigation of care for providers and clinical teams.
Patients can contact Cooper and Inspira Neuroscience at Neuroscience.CooperAndInspira.org or via phone at (855) 30-NEURO. If you have questions about the neuroscience partnership, please contact Matthew Brown at BrownM@ihn.org or Terri Veneziano at VenezianoT@ihn.org.
